Related references
Note: Only part of the references are listed.ASO Author Reflections: Neoadjuvant Chemotherapy for High-Grade Appendiceal Neoplasms Before Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy, Closer to Evidence-Based Practice?
Christopher W. Mangieri et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
Christopher W. Mangieri et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
Utility of hyperthermic intraperitoneal chemotherapy in cases of incomplete cytoreductive surgery
Christopher W. Mangieri et al.
JOURNAL OF SURGICAL ONCOLOGY (2022)
Timing of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Recurrent Low-Grade Appendiceal Mucinous Neoplasms
Cristian D. Valenzuela et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
The Evolving Management of Peritoneal Surface Malignancies
John H. Stewart et al.
CURRENT PROBLEMS IN SURGERY (2021)
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial
Francois Quenet et al.
LANCET ONCOLOGY (2021)
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) might increase the risk of anastomotic leakage compared to HIPEC: an experimental study
Clement Tavernier et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2020)
Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin
Omeed Moaven et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
The Chicago Consensus on Peritoneal Surface Malignancies: Standards
ANNALS OF SURGICAL ONCOLOGY (2020)
Immersion Bioprinting of Tumor Organoids in Multi-Well Plates for Increasing Chemotherapy Screening Throughput
Erin Maloney et al.
MICROMACHINES (2020)
Personalized Identification of Optimal HIPEC Perfusion Protocol in Patient-Derived Tumor Organoid Platform
Steven D. Forsythe et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study
Diane Goere et al.
LANCET ONCOLOGY (2020)
Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications
Mohammad Alyami et al.
LANCET ONCOLOGY (2019)
Re-operations for early postoperative complications after CRS and HIPEC: indication, timing, procedure, and outcome
Sebastian Blaj et al.
LANGENBECKS ARCHIVES OF SURGERY (2019)
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
Charlotte E. L. Klaver et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study
Konstantinos I. Votanopoulos et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma
A. Arjona-Sanchez et al.
BMC CANCER (2018)
Predicting Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendix Adenocarcinoma
Omer Aziz et al.
DISEASES OF THE COLON & RECTUM (2018)
A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors
Edward A. Levine et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2018)
Current Management of Peritoneal Surface Malignancy Preface
Edward A. Levine
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2018)
The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Tumors and Colorectal Adenocarcinomas
Michael Kuncewitch et al.
CLINICS IN COLON AND RECTAL SURGERY (2018)
Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC)
Konstantinos Chouliaras et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Colorectal cancer at high risk of peritoneal metastases; long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives
Charlotte E. L. Klaver et al.
ONCOTARGET (2017)
Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial
P. H. Cashin et al.
EUROPEAN JOURNAL OF CANCER (2016)
Efficacy of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Management of Malignant Ascites
Reese W. Randle et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy
Wiebke Solass et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety Aspects
Wiebke Solass et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome?
D. Hompes et al.
ANNALS OF ONCOLOGY (2012)
Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept
Wiebke Solass et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2012)
Hyperthermic intraperitoneal chemotherapy: Rationale and technique
Santiago Gonzalez-Moreno et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)
Laparoscopic Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) in the Management of Refractory Malignant Ascites: A Multi-Institutional Retrospective Analysis in 52 Patients
M. Valle et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Evidence-Based Medicine in the Treatment of Peritoneal Carcinomatosis: Past, Present, and Future
Aviram Nissan et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer
Vic J. Verwaal et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer
VJ Verwaal et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator
MA Reymond et al.
SURGICAL ENDOSCOPY-ULTRASOUND AND INTERVENTIONAL TECHNIQUES (2000)
Share Paper
